Attached files
| file | filename |
|---|---|
| 10-K - SPEECHSWITCH, INC 10-K 12-31-2009 - Kenergy Scientific, Inc. | form10k.htm |
| EX-32.1 - EXHIBIT 32.1 - Kenergy Scientific, Inc. | ex32_1.htm |
| EX-31.1 - EXHIBIT 31.1 - Kenergy Scientific, Inc. | ex31_1.htm |
| EX-10.15 - EXHIBIT 10.15 - Kenergy Scientific, Inc. | ex10_15.htm |
| EX-10.18 - EXHIBIT 10.18 - Kenergy Scientific, Inc. | ex10_18.htm |
| EX-10.16 - EXHIBIT 10.16 - Kenergy Scientific, Inc. | ex10_16.htm |
| EX-10.11 - EXHIBIT 10.11 - Kenergy Scientific, Inc. | ex10_11.htm |
| EX-10.14 - EXHIBIT 10.14 - Kenergy Scientific, Inc. | ex10_14.htm |
| EX-10.13 - EXHIBIT 10.13 - Kenergy Scientific, Inc. | ex10_13.htm |
| EX-10.12 - EXHIBIT 10.12 - Kenergy Scientific, Inc. | ex10_12.htm |
Exhibit 10.17
PROMISSORY NOTE (No. 005)
(June 18, 2009)
WHEREAS, GlynnTech, Inc. of 24 Mine Street, Flemington, New Jersey has sold patent rights and technology relating to cancer drug delivery systems to SpeechSwitch, Inc. of 750 Highway 34, Matawan, New Jersey under an Agreement of even date herewith, and a portion of the purchase price include three notes for $100,000.00 each (designated as Notes 003, 004 and 005), this being Note 005, and SpeechSwitch, Inc. has agreed to make payment on said Notes one year henceforth, now, therefore,
SpeechSwitch, Inc. agrees to pay GlynnTech, Inc. a sum of $100,000 on or before June 18, 2010, at no interest. This Note shall be in default if not paid in full within 5 days from the due date. No interest shall accrue during the term hereof. However, GlynnTech, Inc. reserves the right to statutory interest after default, at its option.
|
/s/ Kenneth P. Glynn
|
|
|
Kenneth P. Glynn, President, SpeechSwitch, Inc.
|
|
|
/s/ Alex P. Glynn
|
|
|
Alex P. Glynn, Vice President, GlynnTech, Inc.
|